$RHE
Regional Health Properties Inc

2021 Q3 Form 10-Q Financial Statement

#000156459021056700 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3
Revenue $6.702M $4.767M
YoY Change 40.59% -1.3%
Cost Of Revenue $2.454M
YoY Change
Gross Profit $4.248M
YoY Change
Gross Profit Margin 63.38%
Selling, General & Admin $2.765M $3.334M
YoY Change -17.07% 30.75%
% of Gross Profit 65.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $651.0K $694.0K
YoY Change -6.2% -12.92%
% of Gross Profit 15.32%
Operating Expenses $6.074M $4.137M
YoY Change 46.82% 16.93%
Operating Profit $628.0K $630.0K
YoY Change -0.32% -51.24%
Interest Expense $669.0K $692.0K
YoY Change -3.32% -40.19%
% of Operating Profit 106.53% 109.84%
Other Income/Expense, Net -$645.0K -$701.0K
YoY Change -7.99% -115.87%
Pretax Income -$17.00K -$71.00K
YoY Change -76.06% -101.24%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$39.00K -$73.00K
YoY Change -46.58% -101.26%
Net Earnings / Revenue -0.58% -1.53%
Basic Earnings Per Share -$1.27
Diluted Earnings Per Share -$21.97K -$43.25K
COMMON SHARES
Basic Shares Outstanding 1.775M
Diluted Shares Outstanding 1.775M

Balance Sheet

Concept 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.233M $4.646M
YoY Change 34.16% 35.81%
Cash & Equivalents $6.200M $4.600M
Short-Term Investments
Other Short-Term Assets $4.010M $3.505M
YoY Change 14.41% 151.07%
Inventory
Prepaid Expenses
Receivables $1.936M $1.800M
Other Receivables $383.0K $464.0K
Total Short-Term Assets $12.56M $10.41M
YoY Change 20.67% 62.25%
LONG-TERM ASSETS
Property, Plant & Equipment $50.76M $87.75M
YoY Change -42.16% 58.07%
Goodwill $1.585M
YoY Change
Intangibles $12.82M $13.26M
YoY Change -3.31%
Long-Term Investments
YoY Change
Other Assets $514.0K $517.0K
YoY Change -0.58% 598.65%
Total Long-Term Assets $94.46M $99.92M
YoY Change -5.46% -7.44%
TOTAL ASSETS
Total Short-Term Assets $12.56M $10.41M
Total Long-Term Assets $94.46M $99.92M
Total Assets $107.0M $110.3M
YoY Change -3.0% -3.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.918M $2.939M
YoY Change 33.31% -13.69%
Accrued Expenses $4.163M $2.288M
YoY Change 81.95% -74.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.081M $5.227M
YoY Change 54.6% -62.96%
LONG-TERM LIABILITIES
Long-Term Debt $53.40M $54.80M
YoY Change -2.56% 1.42%
Other Long-Term Liabilities $34.67M $38.20M
YoY Change -9.25% 2963.43%
Total Long-Term Liabilities $53.40M $54.80M
YoY Change -2.56% -0.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.081M $5.227M
Total Long-Term Liabilities $53.40M $54.80M
Total Liabilities $96.15M $98.23M
YoY Change -2.12% -5.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.88M $12.11M
YoY Change
Total Liabilities & Shareholders Equity $107.0M $110.3M
YoY Change -3.0% -3.53%

Cashflow Statement

Concept 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$39.00K -$73.00K
YoY Change -46.58% -101.26%
Depreciation, Depletion And Amortization $651.0K $694.0K
YoY Change -6.2% -12.92%
Cash From Operating Activities $1.725M $1.000M
YoY Change 72.5% 33.33%
INVESTING ACTIVITIES
Capital Expenditures -$45.00K -$52.00K
YoY Change -13.46% -64.86%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$45.00K -$52.00K
YoY Change -13.46% -102.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -653.0K -379.0K
YoY Change 72.3% -64.04%
NET CHANGE
Cash From Operating Activities 1.725M 1.000M
Cash From Investing Activities -45.00K -52.00K
Cash From Financing Activities -653.0K -379.0K
Net Change In Cash 1.027M 569.0K
YoY Change 80.49% -74.54%
FREE CASH FLOW
Cash From Operating Activities $1.725M $1.000M
Capital Expenditures -$45.00K -$52.00K
Free Cash Flow $1.770M $1.052M
YoY Change 68.25% 17.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
146000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-122000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-645000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-701000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-71000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
21000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11125000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
123000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-7000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
179000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-39000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10878000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11743000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-14000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
11741000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12165000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13000
us-gaap Profit Loss
ProfitLoss
-521000
us-gaap Profit Loss
ProfitLoss
325000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-97000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-33000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-424000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
358000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1953000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2239000
us-gaap Share Based Compensation
ShareBasedCompensation
302000
us-gaap Share Based Compensation
ShareBasedCompensation
37000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
27000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
144000
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-2150000
us-gaap Straight Line Rent Adjustments
StraightLineRentAdjustments
-765000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
77000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
96000
rhe Noncash Gains Losses On Extinguishment Of Debt
NoncashGainsLossesOnExtinguishmentOfDebt
146000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
77000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
653000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-737000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1482000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-636000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-564000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2977000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-256000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
241000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
345000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4307000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
1933000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-195000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1017000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4112000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
916000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
119000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
209000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-119000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-209000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-119000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-209000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
229000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1710000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1112000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
121000
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
116000
rhe Payment Of Debt Extinguishment And Issuance Costs
PaymentOfDebtExtinguishmentAndIssuanceCosts
21000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1859000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-999000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1859000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-999000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2134000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-292000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7492000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8038000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9626000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7746000
us-gaap Interest Paid Net
InterestPaidNet
2154000
us-gaap Interest Paid Net
InterestPaidNet
1718000
rhe Noncash Payments Of Long Term Debt
NoncashPaymentsOfLongTermDebt
-5044000
rhe Non Cash Debt Issuance Costs And Extinguishment Expenses
NonCashDebtIssuanceCostsAndExtinguishmentExpenses
-102000
rhe Net Payments Through Lender
NetPaymentsThroughLender
-5146000
rhe Noncash Proceeds From Financing
NoncashProceedsFromFinancing
5146000
rhe Net Proceeds Through Lender
NetProceedsThroughLender
5146000
rhe Non Cash Gain On Ppp Loan Forgiveness
NonCashGainOnPPPLoanForgiveness
229000
rhe Vendor Financed Insurance
VendorFinancedInsurance
867000
rhe Vendor Financed Insurance
VendorFinancedInsurance
339000
rhe Non Cash Accruals For Capex
NonCashAccrualsForCapex
-157000
rhe Non Cash Settlement Of Notes Receivable
NonCashSettlementOfNotesReceivable
350000
CY2021Q3 rhe Number Of Facilities
NumberOfFacilities
24
CY2021Q3 rhe Number Of Facilities
NumberOfFacilities
24
rhe Number Of Leased Agreements Executed Owned By Company
NumberOfLeasedAgreementsExecutedOwnedByCompany
10
CY2021Q3 rhe Number Of Sublease Agreements Executed Leased By Company
NumberOfSubleaseAgreementsExecutedLeasedByCompany
8
CY2021Q1 rhe Number Of Sublease Agreements Executed Leased By Company
NumberOfSubleaseAgreementsExecutedLeasedByCompany
1
rhe Number Of Assisted Living Facilities
NumberOfAssistedLivingFacilities
2
rhe Number Of Managed Skilled Nursing Facilities
NumberOfManagedSkilledNursingFacilities
2
CY2021Q3 rhe Number Of Managed Independent Living Facilities
NumberOfManagedIndependentLivingFacilities
1
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
rhe Number Of Facilities On Behalf Of Third Party Owners
NumberOfFacilitiesOnBehalfOfThirdPartyOwners
3
CY2021Q1 rhe Number Of Managed Skilled Nursing Facilities
NumberOfManagedSkilledNursingFacilities
2
CY2021Q3 rhe Percentage Of Anticipated Monthly Rental Receipts From Tenants
PercentageOfAnticipatedMonthlyRentalReceiptsFromTenants
0.97
rhe Percentage Of Anticipated Monthly Rental Receipts From Tenants
PercentageOfAnticipatedMonthlyRentalReceiptsFromTenants
0.97
rhe Minimum Number Of Employees Required Under Employer For Mandatory Vaccinatio
MinimumNumberOfEmployeesRequiredUnderEmployerForMandatoryVaccinatio
100
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.</p>
rhe Percentage Of Additional Allowance For Patient Care Receivables
PercentageOfAdditionalAllowanceForPatientCareReceivables
0.015
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1900000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2100000
CY2021Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2078000
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3481000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
142000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1381000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1936000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2100000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
600000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
300000
CY2021Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3918000
CY2020Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
3008000
CY2021Q3 us-gaap Other Liabilities
OtherLiabilities
1600000
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
1400000
CY2021Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
111000
CY2020Q3 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
134000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
342000
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
379000
CY2021Q3 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
111000
CY2020Q3 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
134000
us-gaap Real Estate Tax Expense
RealEstateTaxExpense
342000
us-gaap Real Estate Tax Expense
RealEstateTaxExpense
379000
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0798
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
71000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
71000
CY2021Q3 rhe Antidilutive Securities Excluded From Computation Of Earnings Per Share Intrinsic Value
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareIntrinsicValue
0
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6200000
CY2021Q3 rhe Medicaid Overpayment
MedicaidOverpayment
1000000.0
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4300000
CY2021Q3 rhe Medicaid Overpayment
MedicaidOverpayment
1000000.0
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
53400000
CY2021Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1300000
CY2021Q3 rhe Long Term Debt Maturities Repayments Of Principal In Next Twelve Months Subject To Non Default In Payments
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsSubjectToNonDefaultInPayments
2000000.0
CY2021Q3 us-gaap Cash
Cash
6233000
CY2020Q4 us-gaap Cash
Cash
4186000
CY2021Q3 us-gaap Replacement Reserve Escrow
ReplacementReserveEscrow
1918000
CY2020Q4 us-gaap Replacement Reserve Escrow
ReplacementReserveEscrow
1675000
CY2020Q4 rhe Escrow Deposit Current
EscrowDepositCurrent
1190000
CY2021Q3 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
317000
CY2020Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
317000
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
3393000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
3306000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9626000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7492000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
73538000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
73613000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22783000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21080000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50755000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52533000
CY2021Q3 us-gaap Land Improvements
LandImprovements
100000
CY2021Q3 us-gaap Depreciation
Depreciation
542000
CY2020Q3 us-gaap Depreciation
Depreciation
537000
us-gaap Depreciation
Depreciation
1625000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
109000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
157000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
328000
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
651000
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
694000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1953000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2239000
CY2020Q4 rhe Finite And Indefinite Lived Intangible Assets Gross
FiniteAndIndefiniteLivedIntangibleAssetsGross
16953000
CY2020Q4 us-gaap Goodwill Gross
GoodwillGross
1585000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3802000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13151000
CY2020Q4 us-gaap Goodwill
Goodwill
1585000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
328000
CY2021Q3 rhe Finite And Indefinite Lived Intangible Assets Gross
FiniteAndIndefiniteLivedIntangibleAssetsGross
16953000
CY2021Q3 us-gaap Goodwill Gross
GoodwillGross
1585000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4130000
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
12823000
CY2021Q3 us-gaap Goodwill
Goodwill
1585000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
109000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
157000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
328000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
608000
rhe Operating Leases Number Of Skilled Nursing Facilities Leased
OperatingLeasesNumberOfSkilledNursingFacilitiesLeased
9
CY2021Q3 rhe Lessee Operating Lease Liability Future Rental Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityFutureRentalPaymentsRemainderOfFiscalYear
1675000
CY2021Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Remainder Of Fiscal Year
LesseeOperatingLeaseAccretionOfLeaseLiabilityRemainderOfFiscalYear
37000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1638000
CY2021Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due Year One
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearOne
6752000
CY2021Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year One
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearOne
468000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6284000
CY2021Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Two
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearTwo
6851000
CY2021Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Two
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearTwo
933000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5918000
CY2021Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Three
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearThree
6958000
CY2021Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Three
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearThree
1385000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5573000
CY2021Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due Year Four
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueYearFour
7095000
CY2021Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due Year Four
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueYearFour
1847000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5248000
CY2021Q3 rhe Lessee Operating Lease Liability Future Rental Payments Due After Year Four
LesseeOperatingLeaseLiabilityFutureRentalPaymentsDueAfterYearFour
12736000
CY2021Q3 rhe Lessee Operating Lease Accretion Of Lease Liability Due After Year Four
LesseeOperatingLeaseAccretionOfLeaseLiabilityDueAfterYearFour
4331000
CY2021Q3 rhe Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
8405000
CY2021Q3 rhe Lessee Operating Lease Liability Future Rental Payments
LesseeOperatingLeaseLiabilityFutureRentalPayments
42067000
CY2021Q3 rhe Lessee Operating Lease Accretion Of Lease Liability
LesseeOperatingLeaseAccretionOfLeaseLiability
9001000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
33066000
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0798
us-gaap Lessor Operating Lease Description
LessorOperatingLeaseDescription
As of September 30, 2021, the Company leased or subleased 20 facilities (12 owned by the Company and eight leased to the Company), to third-party tenants on a triple net basis, meaning that the lessee (i.e., the third-party tenant of the property) is obligated under the lease or sublease, as applicable, for all costs of operating the property, including insurance, taxes and facility maintenance, as well as the lease or sublease payments, as applicable. The weighted average remaining lease term for our facilities is approximately 5.8 years.
rhe Number Of Leased Or Subleased Facilities
NumberOfLeasedOrSubleasedFacilities
20
rhe Operating Leases Number Of Skilled Nursing Facilities Sub Leased
OperatingLeasesNumberOfSkilledNursingFacilitiesSubLeased
8
CY2021Q3 rhe Estimated Allowance On Debt Recovery
EstimatedAllowanceOnDebtRecovery
100000
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
3189000
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
13519000
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
15477000
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
15299000
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
13702000
CY2021Q3 rhe Lessor Operating Lease Payments To Be Received After Year Four
LessorOperatingLeasePaymentsToBeReceivedAfterYearFour
33555000
CY2021Q3 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
94741000
CY2021Q3 rhe Accrued Payroll Related Expenses Current
AccruedPayrollRelatedExpensesCurrent
438000
CY2020Q4 rhe Accrued Payroll Related Expenses Current
AccruedPayrollRelatedExpensesCurrent
218000
CY2021Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1175000
CY2020Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
491000
CY2021Q3 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
140000
CY2020Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
183000
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
222000
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
424000
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
42000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
41000
CY2021Q3 rhe Medicaid Overpayment Healthcare Services
MedicaidOverpaymentHealthcareServices
1032000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1114000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
868000
CY2021Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
4163000
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2225000
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
54720000
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
55824000
CY2021Q3 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1197000
CY2020Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1250000
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
126000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
135000
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
53397000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
54439000
CY2021Q3 rhe Debt Instrument Number Of Credit Related Instruments
DebtInstrumentNumberOfCreditRelatedInstruments
16
CY2021Q3 rhe Long Term Debt Maturities Repayments Of Principal In Rolling Year One
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearOne
1976000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
2333000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
1922000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
2014000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
2110000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
44365000
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
54720000
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
126000
CY2021Q3 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
1197000
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
53397000
CY2021Q3 us-gaap Disposal Group Including Discontinued Operation Accounts Payable Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent
2500000
CY2020Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent
2600000
CY2021Q3 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
700000
CY2020Q4 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
700000
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2021Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
0
CY2021Q3 rhe Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
179000
CY2020Q3 rhe Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
13000
rhe Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
302000
rhe Allocated Share Based Compensation Expense Benefit
AllocatedShareBasedCompensationExpenseBenefit
37000
CY2020Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0
CY2021Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0
CY2021Q3 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
100000
CY2020Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
200000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Additional Information About Entitys Reportable Segments
AdditionalInformationAboutEntitysReportableSegments
i) Real Estate Services, which consists of the leasing and subleasing of long-term care and senior living facilities to third-party tenants, including the Company’s management of three facilities on behalf of third-party owners; and (ii) Healthcare Services, which consists of the operation of the Tara Facility.
CY2021Q3 us-gaap Operating Leases Income Statement Minimum Lease Revenue
OperatingLeasesIncomeStatementMinimumLeaseRevenue
4136000
us-gaap Operating Leases Income Statement Minimum Lease Revenue
OperatingLeasesIncomeStatementMinimumLeaseRevenue
11980000
CY2021Q3 us-gaap Revenues
Revenues
6702000
us-gaap Revenues
Revenues
20251000
CY2021Q3 rhe Patient Care Expense
PatientCareExpense
2454000
rhe Patient Care Expense
PatientCareExpense
6911000
CY2021Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1640000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
4919000
CY2021Q3 us-gaap Management Fee Expense
ManagementFeeExpense
153000
us-gaap Management Fee Expense
ManagementFeeExpense
468000
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
651000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1953000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
972000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2953000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
77000
CY2021Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
204000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
679000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
6074000
us-gaap Operating Expenses
OperatingExpenses
17960000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
628000
us-gaap Operating Income Loss
OperatingIncomeLoss
2291000
CY2021Q3 us-gaap Interest Expense
InterestExpense
669000
us-gaap Interest Expense
InterestExpense
2022000
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
146000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
146000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-122000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2715000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-424000
CY2021Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-17000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-424000
CY2021Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-22000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-97000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-39000
us-gaap Net Income Loss
NetIncomeLoss
-521000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-839000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-645000

Files In Submission

Name View Source Status
0001564590-21-056700-index-headers.html Edgar Link pending
0001564590-21-056700-index.html Edgar Link pending
0001564590-21-056700.txt Edgar Link pending
0001564590-21-056700-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ghxrripfcwpe000001.jpg Edgar Link pending
ghxrripfcwpe000002.jpg Edgar Link pending
ghxrripfcwpe000003.jpg Edgar Link pending
goaso5ofbfnu000001.jpg Edgar Link pending
goaso5ofbfnu000002.jpg Edgar Link pending
gyjerggsnh2s000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rhe-10q_20210930.htm Edgar Link pending
rhe-10q_20210930_htm.xml Edgar Link completed
rhe-20210930.xsd Edgar Link pending
rhe-20210930_cal.xml Edgar Link unprocessable
rhe-20210930_def.xml Edgar Link unprocessable
rhe-20210930_lab.xml Edgar Link unprocessable
rhe-20210930_pre.xml Edgar Link unprocessable
rhe-ex311_9.htm Edgar Link pending
rhe-ex312_8.htm Edgar Link pending
rhe-ex321_7.htm Edgar Link pending
rhe-ex322_6.htm Edgar Link pending
rhe-ex417_921.htm Edgar Link pending
rhe-ex418_873.htm Edgar Link pending
rhe-ex419_872.htm Edgar Link pending
Show.js Edgar Link pending